Discontinued — last reported Q4 '25
Surgical Structural Heart — Net Sales
Edwards Lifesciences Surgical Structural Heart — Net Sales decreased by 1.7% to $253.60M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 20.2%, from $210.90M to $253.60M. Over 4 years (FY 2021 to FY 2025), Surgical Structural Heart — Net Sales shows an upward trend with a 3.7% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase indicates growing adoption or market share in surgical heart valve procedures, while a decrease may signal market saturation or a shift toward transcatheter alternatives.
Detailed definition
This metric represents the total revenue generated from the sale of surgical heart valve therapies and related structura...
Peer comparison
Comparable to surgical cardiovascular device revenue reported by medical technology peers focusing on cardiac surgery and structural heart interventions.
ew_segment_surgical_structural_heart_net_salesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $237.40M | $217.40M | $221.30M | $220.80M | $228.50M | $219.70M | $224.10M | $248.20M | $256.30M | $246.60M | $248.20M | $266.10M | $264.30M | $240.00M | $210.90M | $250.90M | $266.80M | $258.00M | $253.60M |
| QoQ Change | — | -8.4% | +1.8% | -0.2% | +3.5% | -3.9% | +2.0% | +10.8% | +3.3% | -3.8% | +0.6% | +7.2% | -0.7% | -9.2% | -12.1% | +19.0% | +6.3% | -3.3% | -1.7% |
| YoY Change | — | — | — | — | -3.7% | +1.1% | +1.3% | +12.4% | +12.2% | +12.2% | +10.8% | +7.2% | +3.1% | -2.7% | -15.0% | -5.7% | +0.9% | +7.5% | +20.2% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Edwards Lifesciences's surgical structural heart — net sales?
- Edwards Lifesciences (EW) reported surgical structural heart — net sales of $253.60M in Q4 2025.
- How has Edwards Lifesciences's surgical structural heart — net sales changed year-over-year?
- Edwards Lifesciences's surgical structural heart — net sales increased by 20.2% year-over-year, from $210.90M to $253.60M.
- What is the long-term trend for Edwards Lifesciences's surgical structural heart — net sales?
- Over 4 years (2021 to 2025), Edwards Lifesciences's surgical structural heart — net sales has grown at a 3.7% compound annual growth rate (CAGR), from $889.10M to $1.03B.
- What does surgical structural heart — net sales mean?
- Total revenue generated from the sale of surgical heart valve replacement and repair products.